Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Obesity 1Lymphoma, Follicular 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Fluorescence Polarization Immunoassay × Clear all
NCT06114498 2026-01-23

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

National Medical Research Center for Therapy and Preventive Medicine

Active not recruiting
240 enrolled
LymphoidOther

Lymphoma, Follicular, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡